TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$17.03
+0.00 (+0.00%)
Open$17.06
Previous Close$17.03
Day High$17.07
Day Low$17.02
52W High$21.03
52W Low$13.08
Volume—
Avg Volume315.5K
Market Cap883.66M
P/E Ratio16.42
EPS$1.01
SectorPharmaceuticals
Analyst Ratings
Hold
11 analysts
Price Target
+46.5% upside
Current
$17.03
$17.03
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 108.20M | 84.56M | 591.55M |
| Net Income | 106.61M | 74.99M | 75.68M |
| Profit Margin | 98.5% | 93.6% | 12.8% |
| EBITDA | 48.35M | 35.90M | 125.32M |
| Free Cash Flow | — | — | 94.80M |
| Rev Growth | +28.0% | +28.0% | +8.8% |
| Debt/Equity | 0.11 | 0.11 | 1.02 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |